Oxytocin Administration in BDD and OCD

Clinical trial NCT02671266 · COMPLETED

Trial details

NCT number: NCT02671266
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Body Dysmorphic Disorder Obsessive-compulsive Disorder

Start date: 2014-12-01
Primary completion: 2017-10-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.